BASIC TO GENE THERAPY: FASL EXPRESSED IN GENETICALLY ENGINEERED MUSCLES PROTECTS THE GENE THERAPY IMMUNE REJECTION?
- 2 Anni 1997/1999
- 77.469€ Totale Fondi
Descrizione non disponibile
Pubblicazioni Scientifiche
- 2001 JOURNAL OF LEUKOCYTE BIOLOGY
Inhibition of FasL sustains phagocytic cells and delays myogenesis in regenerating muscle fibers
- 1998 NEUROSCIENCE LETTERS
Dystrophin deficient myotubes undergo apoptosis in mouse primary muscle cell culture after DNA damage
